Get the Stockscreener App
13.42
4.48%
-0.63
After Hours:
13.42
Integra Lifesciences Holdings Corp stock is traded at $13.42, with a volume of 681.50K.
It is down -4.48% in the last 24 hours and up +11.00% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$14.05
Open:
$14.06
24h Volume:
681.50K
Relative Volume:
0.65
Market Cap:
$1.05B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
26.84
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
+1.36%
1M Performance:
+11.00%
6M Performance:
+5.75%
1Y Performance:
-44.64%
1-Day Range:
$13.27
$14.28
1-Week Range:
$12.73
$14.35
52-Week Range:
$10.87
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.42 | 1.09B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Holdings of Integra Lifesciences Holdings Corp (IART) are aligned with the stars - setenews.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketWeekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
Will Integra LifeSciences Holdings Corporation (IL3) stock test record highs in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Adversity is less terrifying than hope: Integra Lifesciences Holdings Corp (IART) - Setenews
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - The Manila Times
Integra LifeSciences (Nasdaq: IART) slated for Citi 2025 Global Healthcare Conference - Stock Titan
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - Setenews
A Fresh Look at Integra LifeSciences (IART) Valuation After Recent Share Price Volatility - Yahoo Finance
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Integra LifeSciences (IART) Welcomes CMS Inclusion of Key Produc - GuruFocus
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Finviz
Integra LifeSciences Applauds CMS Ruling on Medicare Payment Schedule Benefiting Skin Substitute Products - Quiver Quantitative
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Barchart.com
How robust is Integra LifeSciences Holdings Corporation (IL3) stock financial positionAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock is recommended by analystsEarnings Summary Report & Weekly Stock Performance Updates - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock vulnerable to rate hikes - newser.com
Prepare Yourself for Liftoff: Acadia Healthcare Company Inc (ACHC) - setenews.com
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock cheap at current valuation2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of reboundJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockTrade Analysis Report & Risk Managed Investment Signals - newser.com
FDA Grants 510(k) Clearance to Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Diagnostic and Interventional Cardiology
Surgical Equipment & ConsumablesSpecialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Is Integra LifeSciences Holdings Corporation stock a buy for dividend growthWeekly Trade Summary & Real-Time Buy Signal Notifications - newser.com
Integra LifeSciences Holdings Corporation stock volume spike explainedStop Loss & Expert Verified Movement Alerts - newser.com
Integra LifeSciences (IART) Stock Trades Up, Here Is Why - Finviz
Nothing is Better Than Integra Lifesciences Holdings Corp (IART) stock at the moment - setenews.com
Integra LifeSciences (IART) Gains FDA Clearance for Cardiac Surg - GuruFocus
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device By Investing.com - Investing.com South Africa
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device - Investing.com
Integra LifeSciences Receives FDA Clearance for CUSA Clarity Ultrasonic Surgical Aspirator in Cardiac Surgery Applications - Quiver Quantitative
Integra LifeSciences Receives FDA 510(k) Clearance for Use - GlobeNewswire
Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock poised for growth2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Integra (NASDAQ: IART) gets FDA 510(k) for CUSA Clarity in cardiac surgery valve repair - Stock Titan
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):